| 标题 |
Abstract CT145: A phase II, multicenter, open-label study (COMPASSION-26) of cadonilimab, a PD-1/CTLA-4 bispecific antibody,combined with chemotherapy (chemo) as first-line therapy for advanced pancreatic ductal adenocarcinoma (PDAC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Research 作者:Wenming Wu; Xiafei Hong; Qi Xu; Gang Jin; Zhihua Li; et al 出版日期:2026-04-18 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)